MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 1301 to 1320 of 166,322 approvalsPage 66 of 8317

Edoxaban Tosilate Tablets

Approval Number: 国药准字H20253525
Registration: Mar 4, 2025

Diprophylline Injection

Approval Number: 国药准字H20253499
Registration: Mar 4, 2025

Nicorandil for Injection

Approval Number: 国药准字H20253491
Registration: Mar 4, 2025

Compound Tropicamide Eye Drops

Approval Number: 国药准字H20253480
Registration: Mar 4, 2025

Agomelatine Tablets

Approval Number: 国药准字H20253553
Registration: Mar 4, 2025

Minoxidil Liniment

Approval Number: 国药准字H20253509
Registration: Mar 4, 2025

Empagliflozin Tablets

Approval Number: 国药准字H20253500
Registration: Mar 4, 2025

Elranatamab Injection

Approval Number: 国药准字SJ20250010
Registration: Mar 4, 2025

Avatrombopag Maleate tablet

Approval Number: 国药准字H20253548
Registration: Mar 4, 2025

Trimebutine Maleate Tablets

Approval Number: 国药准字H20253486
Registration: Mar 4, 2025

Tacrolimus Sustained-release Capsules

Approval Number: 国药准字H20253557
Registration: Mar 4, 2025

Roxadustat Capsules

Approval Number: 国药准字H20253546
Registration: Mar 4, 2025

Metoclopramide Dihydrochloride Injection

Approval Number: 国药准字H20253536
Registration: Mar 4, 2025

Famotidine Injection

Approval Number: 国药准字H20253518
Registration: Mar 4, 2025

Nicorandil for Injection

Approval Number: 国药准字H20253489
Registration: Mar 4, 2025

Lactulose Oral Solution

Approval Number: 国药准字H20253514
Registration: Mar 4, 2025

Epalrestat Tablets

Approval Number: 国药准字H20253534
Registration: Mar 4, 2025

Pentazocine Injection

Approval Number: 国药准字H20253528
Registration: Mar 4, 2025

牡蛎钙

Approval Number: 国药准字H19990203
Registration: Mar 3, 2025

左羟丙哌嗪

Approval Number: 国药准字H20041768
Registration: Mar 3, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.